BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Treatment
15 results:

  • 1. Comparison of outcomes of EUS-guided ablation and surveillance only for pancreatic cystic lesions: a propensity score-matching study (with videos).
    Song YJ; Huh G; Kim EH; Lee JB; Park DH
    Gastrointest Endosc; 2023 Oct; 98(4):585-596.e3. PubMed ID: 37211286
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Patient-centered outcomes in the POLO study of active maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.
    Kindler HL; Yoo HK; Hettle R; Cui KY; Joo S; Locker GY; Golan T
    Cancer; 2023 May; 129(9):1411-1418. PubMed ID: 36811344
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
    Ramanathan S; Prasad M; Vora T; Badira CP; Kembhavi S; Ramadwar M; Khanna N; Laskar S; Muckaden MA; Qureshi S; Banavali S; Chinnaswamy G
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30179. PubMed ID: 36645132
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors.
    Zhu C; Sandilos G; Williamson J; Emery R; Platoff R; Joneja U; Acharya NK; Lin A; Badach J; Zilberman B; Madzo J; Jelinek J; Zhang P; Hong YK
    Surgery; 2023 Apr; 173(4):1045-1051. PubMed ID: 36642656
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Who really benefits from intraperitoneal chemotherapy for advanced ovarian cancer? A treatment-free survival analysis of the AICE trial.
    Xiang L; Shen L; Chen Y; Guo Y; Jiang R; Zhang W; Jia H; Wu Z; Zang R
    BJOG; 2022 Nov; 129 Suppl 2():32-39. PubMed ID: 36485070
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma.
    O'Neill C; Hayat T; Hamm J; Healey M; Zheng Q; Li Y; Martin RCG
    Surgery; 2020 Oct; 168(4):610-616. PubMed ID: 32631655
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
    Konczalla L; Perez DR; Wenzel N; Wolters-Eisfeld G; Klemp C; Lüddeke J; Wolski A; Landschulze D; Meier C; Buchholz A; Yao D; Hofmann BT; Graß JK; Spriestersbach SL; Grupp K; Schumacher U; Betzel C; Kapis S; Nuguid T; Steinberg P; Püschel K; Sauter G; Bockhorn M; Uzunoglu FG; Izbicki JR; Güngör C; El Gammal AT
    Int J Cancer; 2020 Mar; 146(6):1618-1630. PubMed ID: 31291468
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
    Lutgendorf SK; Thaker PH; Arevalo JM; Goodheart MJ; Slavich GM; Sood AK; Cole SW
    Cancer; 2018 Feb; 124(3):580-586. PubMed ID: 29112229
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
    Pelzer U; Blanc JF; Melisi D; Cubillo A; Von Hoff DD; Wang-Gillam A; Chen LT; Siveke JT; Wan Y; Solem CT; Botteman MF; Yang Y; de Jong FA; Hubner RA
    Br J Cancer; 2017 May; 116(10):1247-1253. PubMed ID: 28350787
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis.
    Reni M; Wan Y; Solem C; Whiting S; Ji X; Botteman M
    J Med Econ; 2014 May; 17(5):338-46. PubMed ID: 24654922
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The expression of the pro-apoptotic gene Air is inducible in human pancreatic adenocarcinoma cells.
    d'Avenia M; Rosati A; Belisario MA; Torino M; Torino G; Turco MC; Pascale M
    J Cell Physiol; 2011 Sep; 226(9):2207-12. PubMed ID: 21437899
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
    Lössner D; Abou-Ajram C; Benge A; Reuning U
    Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells.
    Srivastava SK; Singh SV
    Carcinogenesis; 2004 Sep; 25(9):1701-9. PubMed ID: 15117814
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Microcytomorphometric video-image detection of nuclear chromatin in ovarian cancer].
    Grzonka D; Kamiński K; Kaźmierczak W
    Ginekol Pol; 2003 Sep; 74(9):724-8. PubMed ID: 14674115
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. NF-kappaB/rel transcriptional pathway: implications in pancreatic cancer.
    Algül H; Adler G; Schmid RM
    Int J Gastrointest Cancer; 2002; 31(1-3):71-8. PubMed ID: 12622417
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.